Form 4 for KYTX Kyverna Therapeutics, Inc.
Accepted 2026-05-29 16:30:04 ET · period of report 2026-05-27 · accession 0001193125-26-248427 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-29 16:30 | 2026-05-27 | KYTX | Shaw Christi | Executive COB, Dir | F - Tax | $8.59 | -4,194 | 66.7K | -6% | -$36.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-27 | F | D | 4,194 | $8.59 | 66,741 | D | — | — | (F1) Represents the number of shares withheld by and surrendered to the Issuer on May 27, 2026, to satisfy tax withholding obligations that arose in connection with the vesting of a restricted stock unit award for 16,634 shares that vested in full on May 27, 2026. |